Literature DB >> 17404844

Screening preferences of patients at familial risk of colorectal cancer.

Paul C Schroy Iii1, Julie T Glick, Patricia A Robinson, Timothy Heeren.   

Abstract

Our primary objective was to assess the screening preferences of patients at familial risk of colorectal cancer. Asymptomatic subjects aged 18-75 with a single first-degree relative diagnosed with colorectal cancer (n = 48) or polyps (n = 52) were asked to identify a preferred screening strategy, test features influencing their choice, and level of interest in decision-making after reviewing a decision aid describing the pros and cons of currently recommended screening tests. Although both groups preferred colonoscopy, 40% of subjects with a family history of colorectal cancer and 48% of those with a family history of polyps preferred alternative strategies. Accuracy was the most commonly identified test feature influencing test preference. Most subjects (66%) felt that selection of screening test should be a patient dominant or shared process. We conclude that patients at familial risk of colorectal cancer have distinct screening preferences that often vary from current recommendations.

Entities:  

Mesh:

Year:  2007        PMID: 17404844     DOI: 10.1007/s10620-006-9670-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Relatives of colorectal cancer patients: factors associated with screening behavior.

Authors:  Lisa Madlensky; Mary Jane Esplen; Steven Gallinger; John R McLaughlin; Vivek Goel
Journal:  Am J Prev Med       Date:  2003-10       Impact factor: 5.043

2.  American Cancer Society guidelines for the early detection of cancer.

Authors:  Robert A Smith; Vilma Cokkinides; Andrew C von Eschenbach; Bernard Levin; Carmel Cohen; Carolyn D Runowicz; Stephen Sener; Debbie Saslow; Harmon J Eyre
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

3.  Attitudes toward colorectal cancer screening tests.

Authors:  B S Ling; M A Moskowitz; D Wachs; B Pearson; P C Schroy
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

4.  Screening behavior of individuals at high risk for colorectal cancer.

Authors:  Eveline M A Bleiker; Fred H Menko; Babs G Taal; Irma Kluijt; Lidwina D V Wever; Miranda A Gerritsma; Hans F A Vasen; Neil K Aaronson
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

5.  Interest in genetic testing among first-degree relatives of colorectal cancer patients.

Authors:  A Y Kinney; Y A Choi; B DeVellis; E Kobetz; R C Millikan; R S Sandler
Journal:  Am J Prev Med       Date:  2000-04       Impact factor: 5.043

6.  Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic.

Authors:  R S Houlston; V Murday; C Harocopos; C B Williams; J Slack
Journal:  BMJ       Date:  1990 Aug 18-25

7.  Patient preferences for colon cancer screening.

Authors:  M Pignone; D Bucholtz; R Harris
Journal:  J Gen Intern Med       Date:  1999-07       Impact factor: 5.128

8.  Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative.

Authors:  J L Richardson; K Danley; G T Mondrus; D Deapen; T Mack
Journal:  Prev Med       Date:  1995-03       Impact factor: 4.018

9.  Accuracy of reporting of family history of colorectal cancer.

Authors:  R J Mitchell; D Brewster; H Campbell; M E M Porteous; A H Wyllie; C C Bird; M G Dunlop
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 10.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

View more
  1 in total

Review 1.  Patient satisfaction with colonoscopy: a literature review and pilot study.

Authors:  L Chartier; E Arthurs; M J Sewitch
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.